Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ernexa Therapeutics Inc. Director's Dealing 2017

Dec 7, 2017

35259_dirs_2017-12-07_18743883-f685-4196-93a9-3571c4cc56e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2017-12-07

Reporting Person: Simtob Richard Isaac (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-12-07 Common Stock P 4100 $3.95 Acquired 45536 Direct
2017-12-07 Common Stock P 100 $3.97 Acquired 45636 Direct
2017-12-07 Common Stock P 800 $4.00 Acquired 46436 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 155 Indirect

Footnotes

F1: Owned by minor child.